ÌìÏÂÉúÃü¿ÆÑ§Ç°Ñض¯Ì¬Öܱ¨£¨ÎåÊ®Î壩
£¨8.29-9.4/2011£©
Ò»¾º¼¼¹ú¼Ê¼¯ÍÅ:ÌÕ¹úÐÂ
Ö÷ÒªÄÚÈÝ£º¶ËÁ£ÑÓÉìÌæ»»»úÖÆ²»ÒÀÀµ¶ËÁ£Ã¸¾Í¿ÉÒÔά³Ö¶ËÁ£³¤¶È£»ÈËÌå½á³¦¸Éϸ°ûµÄÊèÉ¢ºÍÌåÍâÔöÖ³£»Î¢ÇéÐεÄÖ¬·¾Ï¸°ûµ÷ÀíÆ¤·ô¸Éϸ°û»îÐÔ£»ÄÚÖÊÍøÐ¡¹Ü±ê¼ÇÏßÁ£Ì寯Ëéλµã£»²»¿É±¬·¢ºÍµ÷¶¯LonÂѰ׶Կ¹Ñõ»¯Ñ¹Á¦´Ùʹϸ°ûÐàÂõ£»ÌåÍâʹÓÃ×ÔÉí¸Éϸ°û·Ö½âºÍ×÷Óýºìϸ°ûÓÃÓÚÊäѪ¡£
½¹µã¶¯Ì¬£ºÈËÌå½á³¦¸Éϸ°ûµÄÊèÉ¢ºÍÌåÍâÔöÖ³¡£
1. ¶ËÁ£ÑÓÉìÌæ»»»úÖÆ²»ÒÀÀµ¶ËÁ£Ã¸¾Í¿ÉÒÔά³Ö¶ËÁ£³¤¶È
¡¾¶¯Ì¬¡¿
ÈËÀà°©Ö¢ÑÇÐÍÖб£´æÒ»ÖÖά»¤¶ËÁ£µÄ¶ËÁ£ÑÓÉìÌæ»»»úÖÆ£¨ALT£©¡£Ô¼Äª10%µ½15%µÄÈËÀà°©Ö¢¼ì²â²»µ½¶ËÁ£Ã¸»îÐÔ£¬ÆäÖÐһЩͨ¹ý±»³ÆÎª¶ËÁ£ÑÓÉìÌæ»»»úÖÆµÄ²»ÒÀÀµ¶ËÁ£Ã¸µÄ¶ËÁ£Î¬»¤»úÖÆÎ¬³Ö¶ËÁ£³¤¶È¡£ALT±íÐÍÔÚÈâÁöºÍÐÇÐÎϸ°ûÁöÖÐÏà¶Ô½ÏÁ¿ÆÕ±é£¬¶øÔÚÉÏÆ¤°©±äÖÐÏÊÓб¨µÀ¡£²»¹ý£¬ALTµÄÆÕ±éÐÔ»¹Ã»ÓÐÔÚËùÓа©Ö¢ÀàÐÍÖлñµÃ³¹µ×Åжϡ£ÃÀ¹ú¿ÆÑ§¼Ò¾Í´ËÔÚÆÕ±éµÄÈËÀà°©Ö¢ÖжÔALT±íÐ;ÙÐÐÁË×ÛºÏÊӲ졣×ܹ²Á½¸ö×ÔÁ¦µÄÑù±¾Èº°üÀ¨À´×Ô94ÖÖ²î±ð°©Ö¢ÑÇÐ͵Ä6110ÀýÔ·¢°©Ö¢£¬541ÀýÁ¼ÐÔÖ×Áö£¬ºÍ264ÀýÕý³£×é֯ͨ¹ý¶ËÁ£ÌØÒìÐÔµÄÓ«¹âÔλÔÓ½»ºÍÃâÒßÓ«¹â±ê¼ÇPMLÂѰ×ÏàÍŽáµÄÊÖÒÕ¾ÙÐÐÁËÅжϡ£×ÜÌåÉÏ£¬ÔÚËùÓа©Ö¢Ñù±¾ÖÐ3.73%£¨228/6110£©ÊӲ쵽ALT£¬ÔÚÁ¼ÐÔÖ×ÁöºÍÕý³£×éÖ¯Öж¼Ã»ÓÐÊӲ쵽ALT¡£ÕâÊǵÚÒ»Àý±¨µÀALT·ºÆðÔÚ°òëס¢×Ó¹¬¾±¡¢×Ó¹¬ÄÚĤ¡¢Ê³µÀ¡¢µ¨ÄÒ¡¢Éö¡¢¸ÎºÍ·Î²¿µÄ°©Ö¢ÖС£±ðµÄ£¬ÕâÒ²ÊǵÚÒ»Àý±¨µÀ³ÉÉñ¾¹Üϸ°ûÁö¡¢ÉÙÍ»Éñ¾½ºÖÊÁö¡¢ÄÔĤÁö¡¢Éñ¾ÇÊÁöºÍС¶ù¶ñÐÔ½ºÖÊÁöÖзºÆðALT¡£ÏÈǰµÄÑо¿ÏÔʾALT״̬ºÍijЩ°©Ö¢µÄÔ¤ºóÓйØÏµ£¬Òò´Ë£¬ÐèÒª½øÒ»²½Ñо¿ÆÀ¹ÀALTÑôÐÔµÄÖ×ÁöµÄDZÔÚÔ¤ºóÒâÒåºÍÆæÒìÉúÎïѧ¡£
¡¾µãÆÀ¡¿
Äܹ»Ê¹ÓÃALT;¾¶µÄ°©Ö¢Ô¤ÆÚ»áÄÍÊÜ¿¹¶ËÁ£Ã¸ÖÎÁÆ£¬Òò´Ë¸ÃÑо¿µÄÕâЩЧ¹û¿ÉÄÜ»á¶Ô°©Ö¢ÖÎÁƱ¬·¢Ó°Ï죬ÉîÈëÑо¿ºÍÃ÷È· ALT;¾¶µÄ·Ö×Ó»úÀí¿ÉÄܶÔÉè¼ÆÕë¶ÔʹÓÃALT;¾¶µÄ°©Ö¢µÄÒ©ÎïÓÐÖ÷Òª×÷Óá£
¡¾²Î¿¼ÂÛÎÄ¡¿
The American Journal of Pathology, 2011, 179(4), DOI: 10.1016/j.ajpath.2011.06.018
Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes
Christopher M. Heaphy, Andrea P. Subhawong, Seung-Mo Hong, et al.
Approximately 10% to 15% of human cancers lack detectable telomerase activity, and a subset of these maintain telomere lengths by the telomerase-independent telomere maintenance mechanism termed alternative lengthening of telomeres (ALT). The ALT phenotype, relatively common in subtypes of sarcomas and astrocytomas, has rarely been reported in epithelial malignancies. However, the prevalence of ALT has not been thoroughly assessed across all cancer types. We therefore comprehensively surveyed the ALT phenotype in a broad range of human cancers. In total, two independent sets comprising 6110 primary tumors from 94 different cancer subtypes, 541 benign neoplasms, and 264 normal tissue samples were assessed by combined telomere-specific fluorescence in situ hybridization and immunofluorescence labeling for PML protein. Overall, ALT was observed in 3.73% (228/6110) of all tumor specimens, but was not observed in benign neoplasms or normal tissues. This is the first report of ALT in carcinomas arising from the bladder, cervix, endometrium, esophagus, gallbladder, kidney, liver, and lung. Additionally, this is the first report of ALT in medulloblastomas, oligodendrogliomas, meningiomas, schwannomas, and pediatric glioblastoma multiformes. Previous studies have shown associations between ALT status and prognosis in some tumor types; thus, further studies are warranted to assess the potential prognostic significance and unique biology of ALT-positive tumors. These findings may have therapeutic consequences, because ALT-positive cancers are predicted to be resistant to anti-telomerase therapies.
2. ÈËÌå½á³¦¸Éϸ°ûµÄÊèÉ¢ºÍÌåÍâÔöÖ³
¡¾¶¯Ì¬¡¿
ÔÚÈËÌåÒ»ÉúÖУ¬½á³¦¸Éϸ°ûÿÖÜÔÙÉú¸üÐÂÒ»´Î´ó³¦Äڲ㡣¿ÆÑ§¼Ò¼¸Ê®ÄêÀ´Ö¤Êµ±£´æ½á³¦¸Éϸ°ûµ«Ò»Ö±ÎÞ·¨Ê¶±ðºÍÅжÏËüÃÇ¡£Î÷°àÑÀ¿ÆÑ§¼Ò×î½ü׼ȷ¶¨Î»ÁËÈ´³¦¸Éϸ°ûµÄ±£´æÎ»Öò¢¿ª·¢³öÁËÒ»Ì×ÒªÁìÀ´ÊèÉ¢ºÍÌåÍâ×÷ÓýËüÃÇ£¬µÚÒ»¸ö±¨µÀÁËÈËÌå½á³¦ÉÏÆ¤¸Éϸ°ûµÄÊèÉ¢ºÍÌåÍâ×÷ÓýÔöÖ³¡£Ï¸°ûÍâòBÐ͵ûËØÊÜÌ壨EPHB2£©µÄ²î±ðº¬Á¿Ê¹µÃÄܹ»´ÓÈËÌå½á³¦Õ³Ä¤»î×éÖ¯ÇÐÆ¬ÖÐÊèÉ¢²î±ðÀàÐ͵Äϸ°û¡£Ï¸°ûÍâòº¬Á¿×î¸ßµÄEPHB2 ¶ÔӦמßÓÐ×¶ËÁ£ºÍ¸ß±í´ïµÄ³¦¸Éϸ°û£¨ISC£©±ê¼Ç»ùÒòµÄ½á³¦ÉÏÆ¤Ï¸°û¡£²¢ÇÒ£¬Ê¹Óô´Á¢ISC΢Éú̬ÇéÐεÄ×÷ÓýÌõ¼þ£¬È·ÊµÓÐÒ»²¿·ÖÓиߺ¬Á¿EPHB2µÄϸ°ûÄܹ»ÔÚÌåÍâÔöÖ³³ÉΪ²»·Ö½âµÄ¶àÄÜϸ°ûȺ¡£
¡¾µãÆÀ¡¿
ÀÖ³ÉÊèÉ¢³ö½á³¦¸Éϸ°ûÕâÖÖ³ÉÌå¸Éϸ°û²¢ÌåÍâ×÷Óýºã¾Ãά³ÖÔöÖ³²»·Ö½â»ò¶¨Ïò·Ö½â£¬¹ØÓÚÓóÉÌå¸Éϸ°û½¨ÉèÌåÍâÄ£×ÓÑо¿Î¸³¦µÀϸ°ûµÄÔöÖ³·Ö½â¿ªÆôÁË´óÃÅ£¬Ò²ÎªÌ½Ë÷¸üºÃµÄ³ÉÌå¸Éϸ°û×÷ÓýÌõ¼þ¼°×Åʵ¼ÊÁÙ´²Ó¦ÓõÄת»¯´òÏÂÁË»ù´¡¡£
¡¾²Î¿¼ÂÛÎÄ¡¿
Nature Medicine, 2011; DOI:10.1038/nm.2470
Isolation and in vitro expansion of human colonic stem cells
Peter Jung, Toshiro Sato, Anna Merlos-Su¨¢rez, et al.
Here we describe the isolation of stem cells of the human colonic epithelium. Differential cell surface abundance of ephrin type-B receptor 2 (EPHB2) allows the purification of different cell types from human colon mucosa biopsies. The highest EPHB2 surface levels correspond to epithelial colonic cells with the longest telomeres and elevated expression of intestinal stem cell (ISC) marker genes. Moreover, using culturing conditions that recreate the ISC niche, a substantial proportion of EPHB2-high cells can be expanded in vitro as an undifferentiated and multipotent population.
3. ΢ÇéÐεÄÖ¬·¾Ï¸°ûµ÷ÀíÆ¤·ô¸Éϸ°û»îÐÔ
¡¾¶¯Ì¬¡¿
²¸È鶯ÎïÆ¤·ôÖÐÐèÒª¶àÖÖÀàÐͳÉԱϸ°ûÀ´ÐγÉÓй¦Ð§µÄ×éÖ¯²¢Ö§³Ö×éÖ¯µÄÎȹ̺ÍÔÙÉú¡£×é³ÉÉÏÆ¤¸Éϸ°û΢Éú̬ÇéÐεÄϸ°û»¹²»ÍêÈ«Ïàʶ¡£ÃÀ¹ú¿ÆÑ§¼Ò×î½üÔÚÆ¤·ôÖÐÅжϳöÖ¬·¾Ç°Ìåϸ°û²¢Ö¤ÊµËüÃǵĶ¯Ì¬µÄÔÙÉúƽÐÐÓÚÆ¤·ô¸Éϸ°ûµÄ¼¤»î¡£»¼ÓÐÖ¬·¾ÐγÉÕϰµÄÀÏÊóµÄÒÔ¼°ÒÆÖ²ÊµÑéÖеÄÖ¬·¾Ï¸°ûµÄ¹¦Ð§ÆÊÎöÅú×¢ÕæÆ¤ÄÚµÄÖ¬·¾Ï¸°ûÊǼ¤»îÄÒÅݸÉϸ°ûµÄ³äÒªÌõ¼þ¡£²¢ÇÒ£¬Î´³ÉÊìÖ¬·¾Ï¸°û±í´ïµÄPDGF¿ÉÄÜÔÚµ÷ÀíÄÒÅݸÉϸ°û»îÐÔÉÏÆð×÷Óá£ÕâЩÊý¾Ý͹ÏÔ³öÌìÉúÖ¬·¾µÄϸ°ûÊÇÕýÏòµ÷ÀíÆ¤·ô¸Éϸ°û»îÐÔµÄÆ¤·ô΢Éú̬ÇéÐεÄ×é³Éϸ°û²¢ÌáÐÑÁÙ´²ÉÏÖ¬·¾Ï¸°û¿ÉÄÜ»á¸Ä±äÉÏÆ¤¸Éϸ°ûµÄ¹¦Ð§¡£
¡¾µãÆÀ¡¿
ÄÐÐÔÐÎ̬ÐÔͺ·¢»¼ÕßÔÚëÄÒ¸ù²¿ÉÐÓиÉϸ°û¿ÉÊÇËüÃÇʧȥÁËÆô¶¯Ã«·¢ÔÙÉúµÄÄÜÁ¦£¬¸ÃÑо¿Ö¤ÊµÐÎ³ÉÆ¤·ô¸Éϸ°û΢Éú̬ÇéÐεÄÖ¬·¾Ï¸°ûÄܹ»µ÷ÀíÆ¤·ô¸Éϸ°ûµÄ»îÐÔ£¬ÈôÊÇÓв½·¥Ê¹ÕâЩ֬·¾Ï¸°ûÄܹ»Ó°ÏìëÄÒ¸ù²¿µÄ¸Éϸ°û£¬Ò²Ðí»á´Ùʹë·¢ÖØÐÂÉú³¤¡£ÁíÒ»·½Ã棬¸ÃÑо¿µÄÆôʾÊÇÆ¤·ô¸Éϸ°ûµÄÊʺϵÄÉúÃüÇéÐÎÊÇÖ¬·¾Ï¸°û×é³ÉµÄ£¬Æ¤·ô¸Éϸ°ûµÄÔöÖ³·Ö½âÐèÒªµÄÓªÑøºÍÐźÅÒ²ÊÇÖ¬·¾Ï¸°ûÌṩµÄ¡£
¡¾²Î¿¼ÂÛÎÄ¡¿
Cell, 2011; 146 (5): 761-771 DOI: 10.1016/j.cell.2011.07.019
Adipocyte Lineage Cells Contribute to the Skin Stem Cell Niche to Drive Hair Cycling
Eric Festa, Jackie Fretz, Ryan Berry, et al.
In mammalian skin, multiple types of resident cells are required to create a functional tissue and support tissue homeostasis and regeneration. The cells that compose the epithelial stem cell niche for skin homeostasis and regeneration are not well defined. Here, we identify adipose precursor cells within the skin and demonstrate that their dynamic regeneration parallels the activation of skin stem cells. Functional analysis of adipocyte lineage cells in mice with defects in adipogenesis and in transplantation experiments revealed that intradermal adipocyte lineage cells are necessary and sufficient to drive follicular stem cell activation. Furthermore, we implicate PDGF expression by immature adipocyte cells in the regulation of follicular stem cell activity. These data highlight adipogenic cells as skin niche cells that positively regulate skin stem cell activity, and suggest that adipocyte lineage cells may alter epithelial stem cell function clinically.
4. ÄÚÖÊÍøÐ¡¹Ü±ê¼ÇÏßÁ£Ì寯Ëéλµã
¡¾¶¯Ì¬¡¿
ÏßÁ£Ìåͨ¹ýÆÆËéºÍÈںϵ÷Àí×ÔÉí½á¹¹ºÍÂþÑÜ¡£ÏßÁ£Ì寯ËéÊÜ¿ØÓÚDnm1/Drp1£¬Ò»¸öÎ§ÈÆÏßÁ£ÌåÐγÉÂÝÐýµ÷ÀíÆÆËéµÄÓë·¢¶¯ÂѰ×Ïà¹ØµÄÂѰס£ÔÚÏßÁ£ÌåÍøÂçÖÐʲô¾öÒéÁËÆÆËéλµã»¹ºÜ²»ÇåÎú¡£ÄÚÖÊÍøºÍÏßÁ£ÌåÌåÏÖ³öϸÃÜñîºÏµÄ¶¯Á¦Ñ§ºÍÆÕ±éµÄ½Ó´¥¡£¼ÓÖÝ´óѧµÄ¿ÆÑ§¼ÒÑо¿ÁËÄÚÖÊÍøÊÇ·ñÔÚÏßÁ£Ì寯ËéÖÐÆð×÷Óá£ËûÃÇ·¢Ã÷ÏßÁ£Ì寯Ë鱬·¢ÔÚÄÚÖÊÍøÐ¡¹Ü½Ó´¥ÏßÁ£Ìå²¢µ÷ÀíÕÐļDrp1ǰµÄËõ¶ÌµÄλÖá£Òò´Ë£¬ÄÚÖÊÍøÐ¡¹Ü¿ÉÄÜÔڽ綨ÏßÁ£Ì寯ËéλµãÖÐÆðÆð¾¢µÄ×÷Óá£
¡¾µãÆÀ¡¿
ÏßÁ£Ìåά³ÖÕý³£¹¦Ð§¹ØÓÚϸ°û´úлÊÇÖÁ¹ØÖ÷ÒªµÄ£¬ÏàʶÏßÁ£ÌåÕý³£ÆÆËéµÄ¼ÓÈëÒòËØ¹ØÓÚÏßÁ£Ì寯ËéÕϰÔì³ÉµÄ¹¦Ð§È±ÏݵÄÖÎÁÆÓÐÖ÷ÒªÒâÒå¡£
¡¾²Î¿¼ÂÛÎÄ¡¿
Science, 2011; DOI: 10.1126/science.1207385
ER Tubules Mark Sites of Mitochondrial Division
Jonathan R. Friedman, Laura L. Lackner, Matthew West, et al.
Mitochondrial structure and distribution are regulated by division and fusion events. Mitochondrial division is regulated by Dnm1/Drp1, a dynamin-related protein that forms helices around mitochondria to mediate fission. Little is known about what determines sites of mitochondrial fission within the mitochondrial network. The endoplasmic reticulum (ER) and mitochondria exhibit tightly coupled dynamics and have extensive contacts. We tested whether ER plays a role in mitochondrial division. We found that mitochondrial division occurred at positions where ER tubules contacted mitochondria and mediated constriction prior to Drp1 recruitment. Thus, ER tubules may play an active role in defining the position of mitochondrial division sites.
5. ²»¿É±¬·¢ºÍµ÷¶¯LonÂѰ׶Կ¹Ñõ»¯Ñ¹Á¦´Ùʹϸ°ûÐàÂõ
¡¾¶¯Ì¬¡¿
ÃÀ¹ú¿ÆÑ§¼ÒÑо¿ÁËLonÂѰ×ÓÕµ¼µÄÐàÂõWi-38³ÉÏËάϸ°ûÖеÖÓùÑõ»¯ÂѰ׻ýÀ۵ı£»¤»úÖÆµÄË𻵡£ÏßÁ£ÌåÂѰ׵ÄÑõ»¯ËðÉ˱»ÒÔΪÔö½øÐàÂõÀú³Ì£¬¶øLonÂѰ×ͨ³£½µ½âÕâЩÑõ»¯ËðÉËÂѰס£ÔÚÔçÆÚµÄÈËÌåWi-38³ÉÏËάϸ°û£¬¹ýÑõ»¯ÇâѹÁ¦»áѸËÙÓÕµ¼±¬·¢LonÂѰף¬×èÖ¹»ýÀÛÑõ»¯ËðÉËÂѰף¬±£»¤Ï¸°û»îÁ¦¡£Ïà·´µÄ£¬ÖÐÆÚϸ°ûÔÚÑõ»¯Ñ¹Á¦ÏÂÖ»ÌåÏÖ³ö»ºÂýµÄÓÕµ¼±¬·¢LonÂѰף¬Ñõ»¯ËðÉËÂѰ××îÏÈ»ýÀÛ¡£ºóÆÚ»òÐàÂõµÄϸ°û£¬LonÂѰ׻ù´¡Ë®Æ½ºÜµÍ£¬»ýÀÛµÄÑõ»¯ËðÉËÂѰ×ˮƽºÜ¸ß£¬¶ÔÑõ»¯Ñ¹Á¦µÄ·´Ó¦ÖÐËüÃDz»¿ÉÓÕµ¼±¬·¢LonÂѰף¬ÌåÏÖ³öÒ»Á¬ÔöÌíµÄÑõ»¯ËðÉËÂѰ׻ýÀÛ¡£ÐàÂõϸ°ûÆÆËé³ÉÁ½Èº£¬Ò»ÈºÌåÏÖ³öÕý³£µÄÏßÁ£ÌåÖÊÁ¿¶øÁíһȺÌåÏÖ³öÏÔ×ŵÄÏßÁ£Ìåɥʧ¡£Á½ÈºÏ¸°ûµÄÏßÁ£Ìå¿çĤµçλ¶¼Ï÷ÈõÁË¡£ÕâЩÐàÂõµÄת±äÀàËÆÓÚÔÚÄêÇáϸ°ûÖйرÕLon»ùÒòÔì³ÉµÄЧ¹û¡£¾Ý´ËÑо¿Õß½¨ÒéLonÂѰױ¬·¢µÄѹÁ¦ÓÕµ¼ÐÔµÄËðʧÊÇʹϸ°ûÆ«ÏòÐàÂõµÄÈõ»¯µÄѹÁ¦Ë³Ó¦ÄÜÁ¦Ä£Ê½µÄÒ»²¿·Ö¡£
¡¾µãÆÀ¡¿
¸ÃÑо¿²¿·ÖÚ¹ÊÍÁËÔì³ÉÏßÁ£ÌåÂѰ×Ñõ»¯ºÍϸ°ûÐàÂõµÄÔµ¹ÊÔÓÉ¡£LonÂѰ××÷ΪÖ÷ÒªµÄÏßÁ£Ì忹Ñõ»¯ÂѰ×ÊÇÆäÖеÄÒªº¦ÒòËØ¡£Ò»¾º¼¼ÔÙÉúÎïÖÊÄܹ»ÔöÇ¿ÏßÁ£ÌåÊýÄ¿ºÍ¹¦Ð§£¬ÔÚÕâ¸öÒâÒåÉÏ£¬Ôö½øLonÂѰ׵ı¬·¢£¬×èÖ¹»ýÀÛÑõ»¯ËðÉËÂѰף¬±£»¤Ï¸°û»îÁ¦£¬¼á³Öϸ°û²»ÐàÂõ¡£
¡¾²Î¿¼ÂÛÎÄ¡¿
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2011; DOI: 10.1093/gerona/glr145
Impairment of Lon-Induced Protection Against the Accumulation of Oxidized Proteins in Senescent Wi-38 Fibroblasts
J. K. Ngo, L. C. D. Pomatto, D. A. Bota, et al.
Oxidative damage to mitochondrial proteins is thought to contribute to the aging process, but the Lon protease normally degrades such proteins. In early-passage WI-38 human lung fibroblasts, Lon expression is rapidly induced during H2O2 stress, which prevents the accumulation of oxidized proteins and protects cell viability. In contrast, middle passage cells exhibit only sluggish induction of Lon expression in oxidative stress, and oxidized proteins initially accumulate. Late-passage, or senescent, cells have low basal levels of Lon and high levels of accumulated oxidized proteins; in response to oxidative stress, they fail to induce Lon expression and exhibit continually increasing accumulation of oxidized proteins. Senescent cells separated into two populations, one exhibiting normal mitochondrial mass and a second displaying significant loss of mitochondria; both populations had diminished mitochondrial transmembrane potential. These senescent changes are similar to the effects of Lon silencing in young cells. We suggest that loss of Lon stress inducibility is part of a pattern of diminishing stress adaptability that predisposes cells to senescence.
6. ÌåÍâʹÓÃ×ÔÉí¸Éϸ°û·Ö½âºÍ×÷Óýºìϸ°ûÓÃÓÚÊäѪ
¡¾¶¯Ì¬¡¿
¸Éϸ°ûÌåÍâÉú²úºìѪÇò¿ÉÄÜ»áÊÇÈ¡´ú¹Å°åÊäѪÓÃѪµÄÒ»ÖÖÑ¡Ôñ¡£ÕâÒ»¿´·¨µÄÁÙ´²¿ÉÐÐÐÔÉÐδÆÊÎö¡£·¨¹ú¿ÆÑ§¼Ò×î½üµÄÑо¿¾ÍÕâÒ»ÎÊÌâ¸ø³öÁËÆðÔ´Ò»¶¨µÄÃյס£ËûÃÇʹÓÃÒ»ÖÖ×÷Óý¼Æ»®ÔÊÐíÍâÖÜCD34+ÔìѪ¸Éϸ°û·Ö½âÎªÍøÖ¯ºìϸ°û£¬Éú²úÁËͬÖÖµÄ×÷ÓýµÄºìϸ°û£¬ÔÚ±äÐÎÐÔ¡¢Ã¸º¬Á¿¡¢ÆäѪºìÂѰ×ÍŽáºÍÊÍ·ÅÑõÆøµÄÄÜÁ¦ÒÔ¼°±í´ïѪÐÍ¿¹Ô·½Ãæ¶¼Óй¦Ð§¡£´ËºóÔÚÀÏÊóÌåÄÚ֤ʵ×÷ÓýµÄºìϸ°ûÔÚÌåÄÚÓöµ½ÁËʹÆäÍêÈ«³ÉÊìËùÐèµÄÌõ¼þ¡£ÁÙ´²Ñо¿ÖÐ×¢ÉäÈëÈËÌåÄÚµÄ×÷Óýºìϸ°û´æ»î°ëË¥ÆÚÀàËÆÓÚ×ÔÈ»µÄºìϸ°û£¬Ö¤ÊµÎúËüÃǵÄÖÊÁ¿ºÍ¹¦Ð§ÐÔ¡£
¡¾µãÆÀ¡¿
ÌåÍâʹÓÃ×ÔÉí¸Éϸ°û·Ö½âºÍ×÷Óýºìϸ°ûÓÃÓÚÊäѪ£¬¿ÉÄÜÓÐÖúÓÚ½â¾öѪԴÎÊÌâºÍÃâÒßÇãÔþÎÊÌâ¡£
¡¾²Î¿¼ÂÛÎÄ¡¿
Blood, 2011; DOI: 10.1182/blood-2011-06-362038
Proof of principle for transfusion of in vitro generated red blood cells
Marie-Catherine Giarratana, H¨¦l¨¨ne Rouard, Agn¨¨s Dumont, et al.
In vitro red blood cell (RBC) production from stem cells could represent an alternative to classical transfusion products. Up until now the clinical feasibility of this concept has not been demonstrated. We addressed the question of the capacity of cultured RBC (cRBC) to survive in human. Using a culture protocol permitting erythroid differentiation from peripheral CD34+ HSC, we generated a homogeneous population of cRBC functional in terms of their deformability, enzyme content, capacity of their hemoglobin to fix/release oxygen and expression of blood group antigens. We then demonstrated in the NOD/SCID mouse that cRBC encountered in vivo the conditions necessary for their complete maturation. These data provided the rationale for injecting into one human a homogeneous sample of 1010 cRBC generated under GMP conditions and labeled with 51Cr. The level of these cells in the circulation 26 days after injection lies between 41 and 63 % which compares favorably to the reported half-life of 28 ¡À 2 days for native RBC. Their survival in vivo testifies globally to their quality and functionality. These data establish the proof of principle for transfusion of in vitro generated RBC and path the way towards new developments in transfusion medicine. This study has been registered at clinicaltrials.gov as NCT0929266.